BRCA2 and ovarian carcinoma: With regard to familial cancer phenotype this relatively small cohort does not allow for the uncovering of subtle differences between the BRCA1/2 mutant families, except for the double incidence rate of ovarian cancers in BRCA1 compared to BRCA2 positive families as reported widely before.